Jove
Visualize
Contact Us

Related Experiment Videos

[Therapy of recurrent herpes simplex].

A Eichmann

    Zeitschrift Fur Hautkrankheiten
    |April 15, 1977
    PubMed
    Summary
    This summary is machine-generated.

    Antigen therapy using Lupidon offers a highly effective treatment for recurrent herpes simplex infections. This method shows significant therapeutic benefits with no severe side effects observed in over 1500 patients.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Stop the Divide and Build Coronary Arteries.

    Developmental cell·2021
    Same author

    Control of arterial branching morphogenesis in embryogenesis: go with the flow.

    Cardiovascular research·2005
    Same author

    Hemangioblast commitment in the avian allantois: cellular and molecular aspects.

    Developmental biology·2002
    Same author

    Endogenous origin of the lymphatics in the avian chorioallantoic membrane.

    Developmental dynamics : an official publication of the American Association of Anatomists·2001
    Same author

    Development of the avian lymphatic system.

    Microscopy research and technique·2001
    Same author

    A model for gene therapy of human hereditary lymphedema.

    Proceedings of the National Academy of Sciences of the United States of America·2001
    JoVE
    x logofacebook logolinkedin logoyoutube logo
    ABOUT JoVE
    OverviewLeadershipBlogJoVE Help Center
    AUTHORS
    Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
    LIBRARIANS
    TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
    RESEARCH
    JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
    EDUCATION
    JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
    Terms & Conditions of Use
    Privacy Policy
    Policies

    Area of Science:

    • Immunology
    • Dermatology
    • Virology

    Context:

    • Herpes simplex recidivans presents a significant clinical challenge.
    • Existing treatments for recurrent herpes simplex have limitations.

    Purpose:

    • To evaluate the efficacy and safety of antigen therapy with Lupidon for herpes simplex recidivans.
    • To review clinical reports and controlled studies on Lupidon treatment.

    Summary:

    • Lupidon antigen therapy, administered topically and systemically, was investigated for recurrent herpes simplex.
    • Clinical reports involving over 1500 controlled patients demonstrated good to very good therapeutic effects.
    • Statistically confirmed results from controlled double-blind tests support long-term efficacy.
    • No severe side effects were reported in the large patient cohort.

    Related Experiment Videos

    Impact:

    • Lupidon antigen therapy represents a promising and safe treatment option for herpes simplex recidivans.
    • The findings support the use of long-term antigen therapy for managing recurrent herpes simplex.
    • This research contributes to the understanding of effective antiviral immunotherapies.